Home / Publications / Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity

Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity

Nikolay Sergeyevich Vostrikov 1
Nikolay Sergeyevich Vostrikov
Ilya Fedorovich Lobko 1
Ilya Fedorovich Lobko
Leonid Vasilevich Spirikhin 1
Leonid Vasilevich Spirikhin
Yulia Venerovna Vakhitova 2
Yulia Venerovna Vakhitova
Kazimir Konstantinovich Pivnitsky 3
Kazimir Konstantinovich Pivnitsky
Mansur Sagar'yarovich Miftakhov 1
Mansur Sagar'yarovich Miftakhov
Published 2017-02-27
CommunicationVolume 27, Issue 2, 125-127
9
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Vostrikov N. S. et al. Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity // Mendeleev Communications. 2017. Vol. 27. No. 2. pp. 125-127.
GOST all authors (up to 50) Copy
Vostrikov N. S., Lobko I. F., Spirikhin L. V., Vakhitova Y. V., Pivnitsky K. K., Miftakhov M. S. Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity // Mendeleev Communications. 2017. Vol. 27. No. 2. pp. 125-127.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2017.03.005
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.03.005
TI - Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity
T2 - Mendeleev Communications
AU - Vostrikov, Nikolay Sergeyevich
AU - Lobko, Ilya Fedorovich
AU - Spirikhin, Leonid Vasilevich
AU - Vakhitova, Yulia Venerovna
AU - Pivnitsky, Kazimir Konstantinovich
AU - Miftakhov, Mansur Sagar'yarovich
PY - 2017
DA - 2017/02/27
PB - Mendeleev Communications
SP - 125-127
IS - 2
VL - 27
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2017_Vostrikov,
author = {Nikolay Sergeyevich Vostrikov and Ilya Fedorovich Lobko and Leonid Vasilevich Spirikhin and Yulia Venerovna Vakhitova and Kazimir Konstantinovich Pivnitsky and Mansur Sagar'yarovich Miftakhov},
title = {Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity},
journal = {Mendeleev Communications},
year = {2017},
volume = {27},
publisher = {Mendeleev Communications},
month = {Feb},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.03.005},
number = {2},
pages = {125--127},
doi = {10.1016/j.mencom.2017.03.005}
}
MLA
Cite this
MLA Copy
Vostrikov, Nikolay Sergeyevich, et al. “Side-modified 15-deoxy-Δ12,14-prostaglandin D2, precursor of corresponding PGJ2. Synthesis from cloprostenol and anticancer activity.” Mendeleev Communications, vol. 27, no. 2, Feb. 2017, pp. 125-127. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.03.005.

Abstract

The title compound, a possible precursor of metabolically stable corresponding PGJ2, was obtained from cloprostenol in seven steps. The compound demonstrated cytotoxicity against the HEK 293, Hep G2 and Jurkat cell lines.

References

2.
Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin
Fukushima S., Kishimoto S., Takeuchi Y., Fukushima M.
Advanced Drug Delivery Reviews, 2000
3.
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G.
Nature, 2000
5.
Chemical Implications for Antitumor and Antiviral Prostaglandins:  Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols
Suzuki M., Mori M., Niwa T., Hirata R., Furuta K., Ishikawa T., Noyori R.
Journal of the American Chemical Society, 1997
6.
Designed Prostaglandins with Neurotrophic Activities
Furuta K., Tomokiyo K., Satoh T., Watanabe Y., Suzuki M.
ChemBioChem, 2000
7.
15-Deoxy-Δ12,14-prostaglandin J2
Shibata T., Kondo M., Osawa T., Shibata N., Kobayashi M., Uchida K.
Journal of Biological Chemistry, 2002
8.
15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ
Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., Evans R.M.
Cell, 1995
9.
Prostaglandin J2and Its Metabolites Promote Neurite Outgrowth Induced by Nerve Growth Factor in PC12 Cells
Satoh T., Furuta K., Suzuki M., Watanabe Y.
Biochemical and Biophysical Research Communications, 1999
11.
Solid-Phase Synthesis and Biological Activity of a Combinatorial Cross-Conjugated Dienone Library
Kitade M., Tanaka H., Oe S., Iwashima M., Iguchi K., Takahashi T.
Chemistry - A European Journal, 2006
12.
Polymer-Assisted Solution-Phase Synthesis and Neurite-Outgrowth-Promoting Activity of 15-Deoxy-Δ12,14-PGJ2 Derivatives
Tanaka H., Hasegawa T., Kita N., Nakahara H., Shibata T., Oe S., Ojika M., Uchida K., Takahashi T.
Chemistry - An Asian Journal, 2006
13.
Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-δ7-prostaglandin A1 methyl ester (TEI-9826) integrated in lipid microspheres (Lipo TEI-9826)
Fukushima S., Takeuchi Y., Kishimoto S., Yamashita S., Uetsuki K., Shirakawa S., Suzuki M., Furuta K., Noyori R., Sasaki H., Kikuchi Y., Kita T., Yamori T., Sawada J., Kojima M., et. al.
Anti-Cancer Drugs, 2003
14.
Synthesis of neuroprotective cyclopentenone prostaglandin analogs: Suppression of manganese-induced apoptosis of PC12 cells
Furuta K., Maeda M., Hirata Y., Shibata S., Kiuchi K., Suzuki M.
Bioorganic and Medicinal Chemistry Letters, 2007
15.
Synthesis and in vitro cytotoxicity of cross-conjugated prostaglandin A and J series and their hydroxy derivatives
Żurawiński R., Mikołajczyk M., Cieślak M., Królewska K., Kaźmierczak-Barańska J.
Organic and Biomolecular Chemistry, 2015
17.
G. A. Tolstikov, M.S. Miftakhov, N.S. Vostrikov, O.M. Kuznetsov, V. Kh. Singizova, E.K. Starostin, M.E. Adler, F.A. Valeev and N. A. Danilova, Patent SU 1512065 A1, 1989.
18.
10.1016/j.mencom.2017.03.005_bib0090
Tolstikov
Zh. Org. Khim., 1992